iBio, Inc.
General ticker "IBIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $199.5M (TTM average)
iBio, Inc. does not follow the US Stock Market performance with the rate: -10.5%.
Estimated limits based on current volatility of 5.0%: low 0.74$, high 0.81$
Factors to consider:
- Total employees count: 23 (+15.0%) as of 2026
- Top business risk factors: Limited operating history, Operational and conduct risks, Need additional capital, Regulatory and compliance, Intellectual property risks
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-30 to 2028-06-29
- 2026-06-30 to 2027-06-30 estimated range: [0.85$, 2.85$]
- 2027-06-30 to 2028-06-29 estimated range: [0.75$, 2.55$]
Short-term IBIO quotes
Long-term IBIO plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-30 | 2026-06-30 |
|---|---|---|---|
| Operating Revenue | $0.23MM | $0.40MM | $0.10MM |
| Operating Expenses | $16.86MM | $19.00MM | $35.24MM |
| Operating Income | $-16.63MM | $-18.60MM | $-35.14MM |
| Non-Operating Income | $1.19MM | $0.23MM | $2.10MM |
| Interest Expense | $0.17MM | $0.21MM | $0.05MM |
| R&D Expense | $5.18MM | $8.31MM | $19.64MM |
| Income(Loss) | $-15.44MM | $-18.38MM | $-33.04MM |
| Other Income(Loss) | $-9.46MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-24.91MM | $-18.38MM | $-33.04MM |
| Stockholders Equity | $21.32MM | $14.88MM | $85.71MM |
| Assets | $28.73MM | $23.18MM | $99.11MM |
| Operating Cash Flow | $-18.55MM | $-15.30MM | $-23.22MM |
| Capital expenditure | $0.21MM | $0.02MM | $0.58MM |
| Investing Cash Flow | $0.91MM | $0.74MM | $-32.00MM |
| Financing Cash Flow | $24.49MM | $8.93MM | $103.05MM |
| Earnings Per Share** | $-6.50 | $-1.75 | $-0.32 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.